TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2018

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.

Vicente E Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.